Can-Fite BioPharma Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| CANF.TA | 18H0.F | ABVC | MREO | ARTL | CANTA.ST | |
|---|---|---|---|---|---|---|
| Market cap | 14.86M | 7.02M | 23.37M | 41.52M | 1.30M | 363.43M |
| P/E (TTM) | — | — | — | — | — | 1.9 |
| Forward P/E | -0.6 | — | -2.0 | -12.0 | -1.6 | -1.4 |
| Price/book | 2.2 | -1.6 | 1.7 | 1.8 | -0.1 | 1.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −91.04% | −50.00% | −67.29% | −84.72% | −96.78% | −59.59% |
| Today | −8.78% | −33.33% | −1.56% | −5.45% | −4.14% | +0.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CANF.TA news ›Can-Fite Biopharma Ltd. Announces Piclidenoson Demonstrates Up to 80% Improvement in Kidney Disease Marker in Lowe Syndrome Preclinical Study
Published on 11/12/2026 at 07:05 am EST Can-Fite BioPharma Ltd. announced the publication of "Can-Fite's Piclidenoson Demonstrates Up to 80% Improvement in Kidney Disease Marker in Lowe Syndrome Preclinical Study: Published in Nature…
Can-Fite BioPharma Ltd. Completes Dosing Of First 247 Patients In Pivotal Phase III Psoriasis Study Evaluating Piclidenoson
Published on 11/18/2026 at 08:55 am EST Can-Fite BioPharma Ltd. completed treatment of the first 247 patients in its pivotal Phase III study evaluating Piclidenoson for the treatment of moderate-to-severe plaque psoriasis. The last patient…
Can-Fite BioPharma Ltd. Presents Final Positive Data From Phase IIa Pancreatic Cancer Study Of Namodenoson At ESMO 2026
Published on 10/26/2026 at 07:00 am EDT Can-Fite BioPharma Ltd. announced the presentation of final positive data from its Phase IIa clinical study of namodenoson in advanced pancreatic ductal adenocarcinoma at the European Society for…
Can-Fite BioPharma files $100M mixed securities shelf
16:17 EDT Can-Fite BioPharma (CANF) files $100M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-mo... Can-Fite BioPharma files $100M mixed securities shelf 16:17 EDT Can-Fite BioPharma (CANF)…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.